共 50 条
- [31] A Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Ustekinumab Maintenance Therapy in Moderate - Severe Crohn's Disease Patients: Results From IM-UNITIGASTROENTEROLOGY, 2016, 150 (04) : S157 - S158Sandborn, WilliamFeagan, Brian G.Gasink, ChristopherJacobstein, DouglasGao, Long-LongJohanns, JewelSands, Bruce E.Hanauer, Stephen B.Targan, StephanGhosh, Subratade Villiers, Willem J.Colombel, Jean-FredericLee, ScottDieleman, Levinus A.Katz, SeymourRutgeerts, Paul J.
- [32] Pegozafermin for the Treatment of Severe Hypertriglyceridemia: A Randomized, Double-blind, Placebo-controlled Phase 2 Study (ENTRIGUE STUDY)METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S19 - S20Bhatt, Deepak L.Bays, Harold E.Miller, MichaelParli, TeresaFeng, ShibaoSterling, LuluHartsfield, Cynthia L.Agollah, Germaine D.Mansbach, HankKastelein, John J. P.
- [33] A Multicenter, Randomized, Placebo-controlled, Double-blind Phase 2 Study of SHR0302 versus Placebo in Chinese Subjects with Moderate to Severe Active Rheumatoid Arthritis (RA)ARTHRITIS & RHEUMATOLOGY, 2020, 72Zeng, XiaofengJiang, YingYang, YingLi, Hanying
- [34] Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanerceptJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (01) : 86 - 92Bagel, JerryLynde, CharlesTyring, StephenKricorian, GregoryShi, YifeiKlekotka, Paul
- [35] A randomized, double-blind placebo-controlled study of ustekinumab in Japanese patients with moderate to severe plaque psoriasisJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 17 - 17Igarashi, A.Kato, T.Kato, M.Nakagawa, H.
- [36] Vedolizumab Induction Therapy for Crohn's Disease: Results of Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 TrialAMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S624 - S625Sandborn, WilliamSands, BruceColombel, Jean-FredericFeagan, BrianHanauer, StephenRutgeerts, PaulLukas, MilanFedorak, RichardLee, ScottBressler, BrianXu, JingSankoh, SerapStephens, KristinParikh, AsitFox, IrvingMilch, Catherine
- [37] A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitusEUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (12) : 5307 - 5318Searchfield, Grant D.Robinson, James M.Skarinsky, DavidWang, YiweiAnderson, Jeffery J.
- [38] A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitusEuropean Archives of Oto-Rhino-Laryngology, 2023, 280 : 5307 - 5318Grant D. SearchfieldJames M. RobinsonDavid SkarinskyYiwei WangJeffery J. Anderson
- [39] SARILUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDYANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 60 - 60Huizinga, T. W.Kivitz, A. J.Rell-Bakalarska, M.Fleischmann, R. M.Jasson, M.Radin, A. R.Genovese, M. C.
- [40] Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International StudyARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4041 - 4042Genovese, Mark C.Kivitz, Alan J.Simon Campos, J. AbrahamRell-Bakalarska, MariaFleischmann, Roy M.Jasson, MartineRadin, Allen R.Huang, XiaohongHuizinga, Tom W. J.